Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene glycol, and propylene carbonate. The company also provides derivatives comprising di-methyl acetamide, di-methyl amine hydrochloride, tri-methyl amine hydrochloride, di-ethyl amine hydrochloride, tri-ethyl amine hydrochloride, di-methyl urea, choline chloride, mono-ethyl amine hydrochloride, and benzyl tri ethyl ammonium chloride; and pharma excipients, such as poly vinyl pyrrolidone. In addition, it operates Balaji Sarovar Premiere, a hotel in
| Current Price | ₹2,017.10 |
|---|---|
| Market Cap | ₹6,536 Cr |
| Sector | Materials > Materials > Chemicals |
| Sub-Industry | Specialty Chemicals > 0 |
| P/E Ratio | 39.1 |
| Return on Equity | 8.11% |
| 52-Week Range | ₹968.10 – ₹2,185.00 |
| Beta (1Y) | 0.63 |
| Dividend Yield | 0.55% |
1. Amines & Speciality Chemicals-97.4% 2. Hotel-2.5% 3. Unallocated-0.4%
Balaji Amines Ltd. is trading at ₹2,017.10, with a market capitalisation of ₹6,536 Cr.
Balaji Amines Ltd. operates in the Materials > Materials > Chemicals space (Specialty Chemicals > 0).
Balaji Amines Ltd. has a P/E of 39.1 and a return on equity of 8.11%.